Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG). [electronic resource]
Producer: 20041102Description: 1835-42 p. digitalISSN:- 0008-543X
- Administration, Oral
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
- Cisplatin -- therapeutic use
- Deoxycytidine -- analogs & derivatives
- Dexamethasone -- therapeutic use
- Female
- Humans
- Infusions, Intravenous
- Lymphoma, Non-Hodgkin -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Salvage Therapy
- Stem Cell Transplantation
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.